The combination of Anemarrhenae Rhizoma-Rhellodendri Chinensis Cortex is a commonly used combinatorial medicine in clinical practice, which belongs to the “mutual promotion”. Anemarrhenae Rhizoma-Rhellodendri Chinensis Cortex combination has an anti-inflammatory effect, but the mechanism underlying this effect has not been studied well. In this study, the anti-inflammatory mechanism of Anemarrhenae Rhizoma-Rhellodendri Chinensis Cortex combination was studied using network pharmacology. The results showed that Anemarrhenae Rhizoma-Rhellodendri Chinensis Cortex combination has 182 potential anti-inflammatory targets, of which 29 showed regulatory scores greater than or equal to twice the median value of the common targets of Anemarrhenae Rhizoma, Rhellodendri Chinensis Cortex, and inflammation-PTGS2, PTGS1, RXRA, ADRB2, AR, CHRM1, ADRA1B, CHRM3, F10, NOS3, etc. These targets are closely related to the mechanism of inflammation. GO(gene ontology) function showed that anti-inflammatory targets were involved in RNA polymerase Ⅱ promoter transcriptional regulation, cell proliferation, apoptosis regulation, nitric oxide biosynthesis regulation, etc. The KEGG(Kyoto encyclopedia of genes and genomes) pathway was involved in TNF, HIF-1, PI3K-Akt, FOXO, VEGF, T cell receptor, and Toll-like receptor signaling pathways and insulin resistance pathway, among others. The results suggested that the molecular mechanism of Anemarrhenae Rhizoma-Rhellodendri Chinensis Cortex combination would be the coregulation of various signal pathways, exerting synergistic anti-inflammatory effects. The molecular mechanisms of the effect of Anemarrhenae Rhizoma-Rhellodendri Chinensis Cortex combination studied using network pharmacology provide a scientific basis for its clinical use.